UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells

Autophagy, 2018-12, Vol.14 (12), p.2083-2103

2018

Volltextzugriff (PDF)

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

Nature (London), 2013-07, Vol.499 (7456), p.97-101

2013

Volltextzugriff (PDF)

Transforming Growth Factor-β (TGF-β) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway

The Journal of biological chemistry, 2017-03, Vol.292 (10), p.4302-4312

2017

Volltextzugriff (PDF)

Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets

Hepatobiliary & pancreatic diseases international, 2018-06, Vol.17 (3), p.192-197

2018

Volltextzugriff (PDF)

Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF‐1α/SLC7A11 pathway

Cell proliferation, 2022-01, Vol.55 (1), p.e13158-n/a

2022

Volltextzugriff (PDF)

FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis

Scientific reports, 2016-09, Vol.6 (1), p.33453, Article 33453

2016

Volltextzugriff (PDF)

Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis

Gastroenterology (New York, N.Y. 1943), 2019-09, Vol.157 (3), p.777-792.e14

2019

Volltextzugriff (PDF)

Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH

Nature communications, 2021-01, Vol.12 (1), p.66-15, Article 66

2021

Volltextzugriff (PDF)

Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma

International journal of cancer, 2020-09, Vol.147 (6), p.1519-1527

2020

Volltextzugriff (PDF)

Exosomal miR‐103‐3p from LPS‐activated THP‐1 macrophage contributes to the activation of hepatic stellate cells

The FASEB journal, 2020-04, Vol.34 (4), p.5178-5192

2020

Volltextzugriff (PDF)

P53‐dependent induction of ferroptosis is required for artemether to alleviate carbon tetrachloride‐induced liver fibrosis and hepatic stellate cell activation

IUBMB life, 2019-01, Vol.71 (1), p.45-56

2019

Volltextzugriff (PDF)

Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets

World journal of gastroenterology : WJG, 2016-12, Vol.22 (48), p.10512-10522

2016

Volltextzugriff (PDF)

Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress

European journal of pharmacology, 2016-07, Vol.783, p.92-102

2016

Volltextzugriff (PDF)

Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway

Biomedicine & pharmacotherapy, 2018-10, Vol.106, p.125-133

2018

Volltextzugriff (PDF)

Acute liver failure is regulated by MYC- and microbiome-dependent programs

Nature medicine, 2020-12, Vol.26 (12), p.1899-1911

2020

Volltextzugriff (PDF)

Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells

Journal of virology, 2017-03, Vol.91 (6)

2017

Volltextzugriff (PDF)

Melatonin protects against lipid‐induced mitochondrial dysfunction in hepatocytes and inhibits stellate cell activation during hepatic fibrosis in mice

Journal of pineal research, 2017-05, Vol.62 (4), p.np-n/a

2017

Volltextzugriff (PDF)

Hepatic stellate cells role in the course of metabolic disorders development – A molecular overview

Pharmacological research, 2021-08, Vol.170, p.105739-105739, Article 105739

2021

Volltextzugriff (PDF)

Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2014-04, Vol.59 (4), p.1577-1590

2014

Volltextzugriff (PDF)

Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis

Science translational medicine, 2019-10, Vol.11 (516)

2019

Volltextzugriff (PDF)

Curcumin alleviates lipopolysaccharide induced sepsis and liver failure by suppression of oxidative stress-related inflammation via PI3K/AKT and NF-κB related signaling

Biomedicine & pharmacotherapy, 2016-10, Vol.83, p.302-313

2016

Volltextzugriff (PDF)

PM2.5 induces liver fibrosis via triggering ROS-mediated mitophagy

Ecotoxicology and environmental safety, 2019-01, Vol.167, p.178-187

2019

Volltextzugriff (PDF)

Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells

Molecular immunology, 2019-03, Vol.107, p.29-40

2019

Volltextzugriff (PDF)

SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis

Nature communications, 2020-01, Vol.11 (1), p.240-16, Article 240

2020

Volltextzugriff (PDF)

A role for autophagy during hepatic stellate cell activation

Journal of hepatology, 2011-12, Vol.55 (6), p.1353-1360

2011

Volltextzugriff (PDF)

1 – 25 von 2.139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.919)
Mit Volltextzugriff
(1.883)

Publikationsform

Artikel
(2.136)
Buchkapitel
(3)

Sprache

Englisch
(2.028)
Japanisch
(536)
Chinesisch
(122)
Portugiesisch
(6)
Deutsch
(3)
Spanisch
(1)
Russisch
(1)

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Animals
(1.817)
Science & Technology
(1.782)
Life Sciences & Biomedicine
(1.655)
Hepatic Stellate Cells - Drug Effects
(1.387)
Hepatic Stellate Cells - Metabolism
(1.087)
Male
(1.081)
Rats
(1.004)
Humans
(969)
Hepatic Stellate Cells
(701)
Mice
(658)
Liver Cirrhosis - Pathology
(592)
Fibrosis
(589)
Liver
(569)
Cells, Cultured
(566)
Liver - Drug Effects
(565)
Liver Cirrhosis - Metabolism
(565)
Cell Line
(554)
Liver Fibrosis
(537)
Liver Cirrhosis - Drug Therapy
(511)
Liver - Metabolism
(508)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Hepatology
(76)
Plos One
(67)
Zhonghua Gan Zang Bing Za Zhi
(60)
World Journal Of Gastroenterology : Wjg
(54)
Hepatology
(51)
Biochemical And Biophysical Research Communications
(48)
Liver International
(43)
World Journal Of Gastroenterology
(42)
Scientific Reports
(41)
Gut
(39)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

Transforming Growth Factor-β (TGF-β) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway

Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets

Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF‐1α/SLC7A11 pathway

FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis

Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis

Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH

Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma

Exosomal miR‐103‐3p from LPS‐activated THP‐1 macrophage contributes to the activation of hepatic stellate cells

P53‐dependent induction of ferroptosis is required for artemether to alleviate carbon tetrachloride‐induced liver fibrosis and hepatic stellate cell activation

Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets

Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress

Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway

Acute liver failure is regulated by MYC- and microbiome-dependent programs

Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells

Melatonin protects against lipid‐induced mitochondrial dysfunction in hepatocytes and inhibits stellate cell activation during hepatic fibrosis in mice

Hepatic stellate cells role in the course of metabolic disorders development – A molecular overview

Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma

Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis

Curcumin alleviates lipopolysaccharide induced sepsis and liver failure by suppression of oxidative stress-related inflammation via PI3K/AKT and NF-κB related signaling

PM2.5 induces liver fibrosis via triggering ROS-mediated mitophagy

Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells

SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis

A role for autophagy during hepatic stellate cell activation

Suchergebnisse filtern